{"schema_version":"1","generated_at":"2026-11-05T05:13:05.613Z","data_as_of":"2026-11-04","url":"https://www.findmykol.com/kol/sasha-gupta","json_url":"https://www.findmykol.com/kol/sasha-gupta/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"sasha-gupta","name":"Sasha Gupta","credential":"MD","title":"Assistant Professor, Neurology","specialty":"Neurology","specialty_raw":"Neurology","therapeutic_area":"Neurology","therapeutic_areas":["Neurology"],"institution":"University of California, San Francisco","institution_url":"https://www.findmykol.com/institution/university-of-california-san-francisco","city":"San Francisco","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1699161927","orcid":"0000-0002-1972-7301","openalex":"A5102884669"},"summary":"Sasha Gupta is Assistant Professor, Neurology at University of California, San Francisco. OpenAlex indexes 52 publications with 2,621 citations (h-index 26); ClinicalTrials.gov lists 1 registered study with this person as an investigator.","overview":{"text":"Sasha Gupta, MD, is Assistant Professor, Neurology at University of California, San Francisco. The public record shows 52 publications with 2,621 citations (h-index 26), centered on interferon and immune responses, T-cell and B-cell Immunology, Multiple Sclerosis Research Studies. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 5 companies, 1 NIH-funded awards (2025–2026).","bullets":["Most recent indexed publication: 2026 · medRxiv","Top research focus: interferon and immune responses","1 registered trials on ClinicalTrials.gov","Open Payments reporting from 5 companies"],"generated_at":"2026-11-04"},"focus":{"indications":[{"label":"Multiple Sclerosis","therapeutic_area":"Neurology","trials":1,"topics":0,"strength":4},{"label":"Glaucoma","therapeutic_area":"Ophthalmology","trials":0,"topics":0,"strength":1},{"label":"Lupus (SLE)","therapeutic_area":"Rheumatology/Immunology","trials":0,"topics":0,"strength":1},{"label":"Psoriasis / Psoriatic Arthritis","therapeutic_area":"Rheumatology/Immunology","trials":0,"topics":0,"strength":1},{"label":"Lymphoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Psoriasis (Derm)","therapeutic_area":"Dermatology","trials":0,"topics":0,"strength":1},{"label":"Multiple Myeloma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Leukemia (AML/ALL/CML/CLL)","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Myasthenia Gravis","therapeutic_area":"Neurology","trials":0,"topics":0,"strength":1},{"label":"CIDP / Inflammatory Neuropathy","therapeutic_area":"Neurology","trials":0,"topics":0,"strength":1}],"research_topics":["interferon and immune responses","T-cell and B-cell Immunology","Multiple Sclerosis Research Studies","Cytokine Signaling Pathways and Interactions","CAR-T cell therapy research"],"drugs_studied":{"total":4,"shown":3,"withheld":1,"rows":[{"name":"Tysabri","generic":"Natalizumab","trials":0,"payments":2,"publications":0,"mentions":2},{"name":"Briumvi","generic":"Ublituximab","trials":0,"payments":1,"publications":0,"mentions":1},{"name":"Carvykti","generic":"Ciltacabtagene autoleucel","trials":0,"payments":1,"publications":0,"mentions":1}]},"works_with":{"total":6,"shown":3,"withheld":3,"rows":[{"name":"Genentech USA, Inc.","trials":0,"payments":7,"mentions":7},{"name":"Biogen, Inc.","trials":0,"payments":2,"mentions":2},{"name":"Bruce Cree","trials":1,"payments":0,"mentions":1}]}},"scholarship":{"works_count":52,"cited_by_count":2621,"h_index":26,"i10_index":32,"pubmed_count":4,"latest_activity_year":2026,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT06451159","title":"A Study of KYV-101, a CD19 CAR T Cell Therapy, in Participants With Treatment Refractory Progressive Multiple Sclerosis","phase":"PHASE1","status":"ACTIVE_NOT_RECRUITING","role":"Investigator","sponsor":"Bruce Cree","source_url":"https://clinicaltrials.gov/study/NCT06451159","trial_url":"https://www.findmykol.com/trial/NCT06451159"}],"source":"trials"},"payments":{"company_count":5,"program_years":{"first":2023,"last":2025},"rows_total":6,"shown":3,"withheld":3,"rows":[{"payer":"Genentech USA, Inc.","program_year":2025,"amount_usd":7794.86,"payment_count":7,"source_url":"https://openpaymentsdata.cms.gov/search?query=1699161927"},{"payer":"Janssen Global Services, LLC","program_year":2025,"amount_usd":2087.5,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1699161927"},{"payer":"Biogen, Inc.","program_year":2025,"amount_usd":150,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1699161927"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1699161927","source":"payments"},"funding":{"award_count":1,"fiscal_years":{"first":2025,"last":2026},"rows_total":2,"shown":2,"withheld":0,"rows":[{"project":"K08NS135120","title":"Allogenic Viral Specific Engineered T Cell for treatment of PML","fiscal_year":2026,"amount_usd":239490,"organization":"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","source_url":"https://reporter.nih.gov/quickSearch/K08NS135120"},{"project":"K08NS135120","title":"Allogenic Viral Specific Engineered T Cell for treatment of PML","fiscal_year":2025,"amount_usd":239490,"organization":"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","source_url":"https://reporter.nih.gov/quickSearch/K08NS135120"}],"source":"grants"},"congress":{"count":5,"years":{"first":2022,"last":2025},"societies":["AAN","ASH"],"shown":3,"withheld":2,"rows":[{"title":"An Investigator Initiated Study of KYV-101, a CD19 CAR T Cell Therapy, in Participants with Treatment Refractory Progressive Multiple Sclerosis (S3.002)","society":"AAN","meeting":"AAN Annual Meeting","year":2025,"role":"presenting_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1212/wnl.0000000000211457","source_url":"https://doi.org/10.1212/wnl.0000000000211457","status":"verified"},{"title":"T-cell Therapy for Progressive Multifocal Leukoencephalopathy (S25.006)","society":"AAN","meeting":"AAN Annual Meeting","year":2024,"role":"presenting_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1212/wnl.0000000000204765","source_url":"https://doi.org/10.1212/wnl.0000000000204765","status":"verified"},{"title":"A Study of Kyv-101, a CD19 CAR T Cell Therapy, in Participants with Treatment Refractory Progressive Multiple Sclerosis","society":"ASH","meeting":"ASH Annual Meeting","year":2024,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1182/blood-2024-204169","source_url":"https://doi.org/10.1182/blood-2024-204169","status":"verified"}],"source":"congress"},"publications":{"total":4,"shown":4,"withheld":0,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Immune Profiling after treatment with an Anti-CD19 Chimeric Antigen Receptor T Cell Therapy in Treatment-Refractory Progressive Multiple Sclerosis.","year":2026,"journal":"medRxiv : the preprint server for health sciences","types":["Journal Article","Preprint"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42818477/","status":"verified"},{"title":"Development of a Diagnostic Autoantibody Assay to a Consensus Motif for the Risk Prediction of Epstein-Barr Virus-Related Multiple Sclerosis.","year":2026,"journal":"Neurology(R) neuroimmunology & neuroinflammation","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41824923/","status":"verified"},{"title":"Programming tissue-sensing T cells that deliver therapies to the brain.","year":2024,"journal":"Science (New York, N.Y.)","types":["Journal Article","Research Support, N.I.H., Extramural","Research Support, Non-U.S. Gov't"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/39636984/","status":"verified"},{"title":"Antigen-Specific T Cell Receptor Discovery for Treating Progressive Multifocal Leukoencephalopathy.","year":2024,"journal":"bioRxiv : the preprint server for biology","types":["Journal Article","Preprint"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/39574748/","status":"verified"}],"source":"publications"},"presence":{"owned_accounts":{"total":2,"shown":2,"rows":[{"platform":"doximity","url":"https://www.doximity.com/pub/sasha-gupta-md","status":"verified"},{"platform":"linkedin","url":"https://www.linkedin.com/in/sasha-gupta-26b163196","status":"provisional"}]},"mentions":{"total":4,"shown":3,"rows":[{"url":"https://encephalitis.ucsf.edu/our-team/","platform":"other","status":"verified"},{"url":"https://profiles.ucsf.edu/sasha.gupta","platform":"other","status":"verified"},{"url":"https://www.aan.com/research/program-recipients","platform":"other","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":1,"shown":1,"rows":[{"value":"MD, Yale School of Medicine (05/2015)","source_url":"https://profiles.ucsf.edu/sasha.gupta","status":"verified","collected_at":"2026-11-04"}]},"awards":{"total":1,"shown":1,"rows":[{"value":"Career Development Award, American Academy of Neurology (2025)","source_url":"https://wilsonlab.ucsf.edu/news-0","status":"verified","collected_at":"2026-11-04"}]},"secondary_affiliations":{"total":2,"shown":2,"rows":[{"value":"UCSF Weill Institute for Neurosciences","source_url":"https://profiles.ucsf.edu/sasha.gupta","status":"verified","collected_at":"2026-11-04"},{"value":"UCSF Center for Encephalitis & Meningitis (team member)","source_url":"https://encephalitis.ucsf.edu/our-team/","status":"verified","collected_at":"2026-11-04"}]}},"similar":[{"name":"Talmadge King","slug":"talmadge-king","institution":"University of California, San Francisco","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/talmadge-king","json_url":"https://www.findmykol.com/kol/talmadge-king/profile.json"},{"name":"Adil Daud","slug":"adil-daud","institution":"University of California, San Francisco","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/adil-daud","json_url":"https://www.findmykol.com/kol/adil-daud/profile.json"},{"name":"Emmanuelle Waubant","slug":"emmanuelle-waubant","institution":"University of California, San Francisco","specialty":"Neurology","url":"https://www.findmykol.com/kol/emmanuelle-waubant","json_url":"https://www.findmykol.com/kol/emmanuelle-waubant/profile.json"},{"name":"Peter Ganz","slug":"peter-ganz","institution":"University of California, San Francisco","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/peter-ganz","json_url":"https://www.findmykol.com/kol/peter-ganz/profile.json"},{"name":"Bruce Miller","slug":"bruce-miller","institution":"University of California, San Francisco (UCSF)","specialty":"Neurology","url":"https://www.findmykol.com/kol/bruce-miller","json_url":"https://www.findmykol.com/kol/bruce-miller/profile.json"},{"name":"Brett Kissela","slug":"brett-kissela","institution":"Medical College of Wisconsin","specialty":"Neurology","url":"https://www.findmykol.com/kol/brett-kissela","json_url":"https://www.findmykol.com/kol/brett-kissela/profile.json"},{"name":"Richard Lipton","slug":"richard-lipton","institution":"Albert Einstein College of Medicine","specialty":"Neurology","url":"https://www.findmykol.com/kol/richard-lipton","json_url":"https://www.findmykol.com/kol/richard-lipton/profile.json"},{"name":"Bradley Boeve","slug":"bradley-boeve","institution":"Mayo Clinic","specialty":"Neurology","url":"https://www.findmykol.com/kol/bradley-boeve","json_url":"https://www.findmykol.com/kol/bradley-boeve/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":3,"congress":2}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-04"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-04"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2023 to 2025","collected_at":"2026-11-04"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year","collected_at":"2026-11-04"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-11-04"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-11-04"}},"methodology_url":"https://www.findmykol.com/about#methodology"}